참고문헌
- Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 2004. 1695: 189-207. https://doi.org/10.1016/j.bbamcr.2004.10.003
- Anderson DC, Cranford RE. Glucocorticoids in ischemic stroke. Stroke 1979. 10: 68-71. https://doi.org/10.1161/01.STR.10.1.68
- Baek KH. Conjugation and deconjugation of ubiquitin regulating the destiny of proteins. Exp Mol Med. 2003. 35: 1-7. https://doi.org/10.1038/emm.2003.1
- Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006. 125: 443-451. https://doi.org/10.1016/j.cell.2006.04.014
- Cai SY, Babbitt RW, Marchesi VT. A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. Proc Natl Acad Sci USA. 1999. 96: 2828-2833. https://doi.org/10.1073/pnas.96.6.2828
- Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: Effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987. 21. 157-160. https://doi.org/10.1227/00006123-198708000-00004
- Craig MA, Beppler GA, Santos C, Raffa RB. A second (nongenomic) steroid mechanism of action: possible opportunity for novel pharmacotherapy? J Clin Pharm Ther. 2005. 30: 305-312. https://doi.org/10.1111/j.1365-2710.2005.00664.x
- Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine 2006. 31: E250-E253. https://doi.org/10.1097/01.brs.0000214886.21265.8c
- Gomes JA, Stevens RD, Lewin JJ 3rd, Mirski MA, Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Crit Care Med. 2005. 33: 1214-1224. https://doi.org/10.1097/01.CCM.0000166389.85273.38
- Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 2004. 5: 253-261. https://doi.org/10.1016/S1535-6108(04)00055-8
- Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg. 1992. 76: 13-22. https://doi.org/10.3171/jns.1992.76.1.0013
- Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: Diabetes 2002. 51 Suppl 3: S455 -S461. https://doi.org/10.2337/diabetes.51.2007.S455
- Nishikawa S, Brodsky JL, Nakatsukasa K. Roles of molecular chaperones in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). J Biochem (Tokyo). 2005. 137: 551-555. https://doi.org/10.1093/jb/mvi068
- Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003. 4: 544-558. https://doi.org/10.1038/nrg1111
- Sayer FT, Kronvall E, Nilsson OG. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J. 2006. 6: 335-343. https://doi.org/10.1016/j.spinee.2005.11.001
- Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005. 569: 29-63. https://doi.org/10.1016/j.mrfmmm.2004.06.056
- Schroder M, Kaufman RJ. Divergent roles of IRE1alpha and PERK in the unfolded protein response. Curr Mol Med. 2006. 6: 5-36. https://doi.org/10.2174/156652406775574569
- Sinha S, Bastin ME, Wardlaw JM, Armitage PA, Whittle IR. Effects of dexamethasone on peritumoural oedematous brain: A DT-MRI study. J Neurol Neurosurg Psychiatry 2004. 75: 1632-1635. https://doi.org/10.1136/jnnp.2003.028647
- Sulea T, Lindner HA, Menard R. Structural aspects of recently discovered viral deubiquitinating activities. Biol Chem. 2006. 387: 853-862. https://doi.org/10.1515/BC.2006.108
- van Laar T, van der Eb AJ, Terleth C. Mif1: a missing link between the unfolded protein response pathway and ER-associated protein degradation? Curr Protein Pept Sci. 2001. 2: 169-190. https://doi.org/10.2174/1389203013381189